People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Software / Tech, Other, Pharmaceuticals, Computers, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mullen Technologies, Inc. | — | Software / Tech | Growth/Late | $505.6M | $15.3M | 2017 |
| Ralco Holdings, Inc. | — | Other | Series C | $154.7M | $1.7B | 2009 |
| Trillium Therapeutics Inc. | — | Pharmaceuticals | Series B | $20.0M | $679.2M | 2017 |
| Terbium Labs, Inc. | — | Computers | Series A | $18.7M | $132.9M | 2015 |
| AxoSim, Inc. | — | Biotechnology | Series A | $17.4M | $22.3M | 2019 |
| Pathware, Inc. | — | Other Health Care | Series A | $12.1M | $102.2M | 2018 |
| Viemed Healthcare, Inc. | — | Healthtech | Seed | $2.9M | $79.9M | 2018 |
| RMG Golf Course Management LLC | — | Other | Seed | $2.9M | $11.6M | 2012 |
| Precipitate Gold Corp | — | Mining & Resources | Pre-Seed | $1.1M | $534K | 2013 |
| Revolution Resources Corp. | — | Other | Pre-Seed | $840K | $4.1M | 2011 |
| Fop Spv I, Llc | — | Investment Vehicle | Pre-Seed | $750K | $16.9M | 2020 |
| Agoge Life, Inc. | — | Other | Pre-Seed | $175K | $710K | 2024 |
Michael Moore at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Moore on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Williams | 1 | 27 |
| Quinton Hennigh | 1 | 10 |
| Robert McLeod | 1 | 10 |
| Adrian Fleming | 1 | 8 |
| Michael Weiss | 1 | 8 |
| Richard Grinnell | 1 | 8 |
| Darryl Cardey | 1 | 7 |
| Justin Moore | 1 | 7 |
| Michael Katz | 1 | 6 |
| Daniel Rogers | 1 | 6 |
| Jeffrey Wilson | 1 | 6 |
| JAMES PARSONS | 1 | 6 |
| Gary Freeman | 1 | 6 |
| Bryan Slusarchuk | 1 | 5 |
| David Oros | 1 | 5 |
| Michael Rose | 1 | 5 |
| Jonathan Richards | 1 | 5 |
| Jeffrey Silverman | 1 | 4 |
| Aaron Keay | 1 | 4 |
| Christopher Wright | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.